Corpus Intelligence NEW YORK-PRESBYTERIAN/BROOKLYN METHO 2026-04-26 02:07 UTC
NEW YORK-PRESBYTERIAN/BROOKLYN METHO
CCN 330236 — BROOKLYN, NY — 516 beds
🛡️ Public data only — no PHI permitted on this instance.
HOSP

NEW YORK-PRESBYTERIAN/BROOKLYN METHO

CCN 330236|LOC BROOKLYN, NY|BEDS 516|NPR $658.2M|MARGIN -20.5%
48
D
SeekingChartis Score
INVESTMENT THESIS
Selective: NEW YORK-PRESBYTERIAN/BROOKLYN METH
56
/ 100 (C)
+$48.4M
EBITDA Uplift
+736bps
Margin Δ
0.0%
Op Margin
$658.2M
Revenue
Realization
Peer Rank
SIGNAL STRENGTH
Margin
0.0%
Safety
58%
CATALYSTS
RCM uplift of $48.4M (+736bps)
Platform-sized facility
RISKS
Elevated distress risk (42%)
Hold / Selective — investigate specific opportunities but be prepared for execution risk.
Peer AnalysisEBITDA BridgeData RoomIC MemoML Detail
$658.2M
Net Patient Revenue
-20.5%
Operating Margin
$-135.0M
Net Income
516
Licensed Beds
$1,276K
Revenue per Bed
$793.2M
Operating Expenses

Payer Mix

PYR
■ MEDICARE · 26%■ MEDICAID · 5%■ COMMERCIAL · 69%

Score Breakdown

SCComposite · 48/100
ComponentScoreMax%Distribution
Market Position293583%
Financial Health32510%
Operational Quality0200%
Competitive Moat72034%

Team Notes

NOTE0 entries

Actions

ACT
WFDiligence Workflow
Competitive IntelEBITDA BridgeData RoomIC MemoScenarios
AIDeep Analysis
ML AnalysisDemand3-Year HistoryStatsBayesian
FINFinancial Models
DCFLBO3-StatementReturnsMarketDenial
MORE IN NYStart Diligence · creates a deal from HCRIS